Simmons Hanly Conroy lawyers are currently investigating serious bleeding incidents in the brain and gastrointestinal track linked to the use of Xarelto, an alternative oral anticoagulant drug prescribed to prevent blood clots.
Xarelto bleeding lawsuits are now being filed against Bayer and Jassen Pharmaceuticals as a result of serious uncontrollable bleeding incidents experienced by patients who took the alternative oral anticoagulant drug to prevent blood clots. Unlike Warfin, the traditional blood thinning drug, there is no current reversal agent for Xarelto, making it a particularly dangerous drug.
Xarelto is a blood thinner taken once daily to prevent the formation of blood clots. Because the drug is designed to stop the blood from clotting, there is a possibility that any injury – even a minor one – can be very dangerous.
Xarelto was approved by the U.S. Food & Drug in 2011 to treat the following:
Xarelto was invented and manufactured by Bayer before 2008. In the United States, it is marketed by Jassen Pharmaceuticals, a division of Johnson & Johnson, as an alternative to Warfin because Xarelto does not require blood monitoring. However, many users have found that the convenience of Xarelto does not warrant its risk of serious side effects.
The Institute for Safe Medication Practices (ISMP), an independent health nonprofit group that monitors FDA MedWatch Reports, has called anticoagulant drugs, like Xarelto and Pradaxa, “a high-risk treatment that causes bleeding in approximately 15 percent of patients with atrial fibrillation exposed for a year.”
In 2012, the FDA received hundreds of reports of adverse effects in Xarelto users. Then another 638 adverse reports linked to Xarelto use were submitted to the FDA in early 2013. ISMP cited the increase to more prescriptions of Xarelto being dispensed. In 2014, Xarelto was the anticoagulant most commonly prescribed and reported to the FDA for severe adverse effects, surpassing Pradaxa by a significant amount.
Many of the adverse effects noted in the reports were related to dangerous internal bleeding. In fact, Xarelto has been linked to an increased risk of uncontrollable bleeding. The potentially fatal bleeding is a result of how the drug affects blood clotting in the proteins – a commonality among most anticoagulant (blood thinning) medications. However, Xarelto stands apart from other blood thinners because there is no reversal method once the internal bleeding has begun.
Because of Xarelto’s increased risk of uncontrollable bleeding, the FDA rejected a bid from Bayer and J&J to approve the drug for use in prevention of new heart attacks and strokes in patients with acute coronary syndrome. According to Reuters, FDA panel members said the benefit of the drug was not shown to outweigh an increased risk of bleeding.
If you or someone you love has been harmed by Xarelto, you may have legal rights. Our legal advocates are available to help.make an appointment
Xarelto can cause serious bleeding because of how it affects blood clotting proteins. Notify your doctor immediately if you notice any of the following signs of serious bleeding while taking Xarelto:
"I am very pleased and had a wonderful experience with the firm. Would definitely use their services again."
"I appreciate all that the Simmons firm has done for me. I’m thrilled with the result they got for me and want to say thanks to everyone there."
"I lost my wife to a heart attack caused by a dangerous drug. While nothing I do will ever bring her back, the Simmons firm helped ensure that other people won’t have to suffer the same loss as me. That product is no longer on the market and the company responsible for selling it to my wife paid a heavy financial price for hurting people like her."
"My mom had a catastrophic stroke as a result of taking a weight-loss product. The Simmons firm fought tirelessly to get her the best result possible. Thanks to them we can afford to get her the medical and therapeutic care she needs."